SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HEMAGEN DIAGNOSTICS (HMGN) -- Ignore unavailable to you. Want to Upgrade?


To: Neurogenesis who wrote (15)8/6/1998 5:48:00 PM
From: Lee Ring  Read Replies (1) | Respond to of 98
 
Is there anyone out there??????????? Drifting, Drifting, Drifting, Drifting,



To: Neurogenesis who wrote (15)12/21/1998 1:50:00 PM
From: Walter Morton  Read Replies (1) | Respond to of 98
 
With the price at $.75 and the p/e ratio below eleven HMGN must be looking good to CIST now. HMGN is ripe for the taking. If HMGN drops anymore CIST will have to compete with a lot of other companies to buy or merge with HMGN.